<DOC>
	<DOCNO>NCT02523196</DOCNO>
	<brief_summary>This study plan learn new test look liver function , HepQuant-Shunt ( HQ-Shunt ) . The HQ-Shunt evaluate safety effectiveness alternative Hepatic Venous Pressure Gradient test patient liver disease .</brief_summary>
	<brief_title>Correlation Comparison HepQuantÂ® Disease Severity Index ( DSI ) With Hepatic Venous Pressure Gradient ( HVPG )</brief_title>
	<detailed_description>The goal study demonstrate HQ-SHUNT safe , simple administer , noninvasive , cost-effective , well tolerated patient . This study compare HQ-SHUNT Hepatic Venous Pressure Gradient ( HVPG ) test . In study , 100 consecutive patient various etiology liver disease undergone technically successful HVPG test standard care also undergo HQ-SHUNT testing .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Liver disease patient schedule Hepatic Venous Pressure Gradient ( HVPG ) procedure At time enrollment , age 18 75 Concomitant treatment beta blocker ACE inhibitor Concurrent hepatic malignancy . Patients history treat HCC include evidence recurrent disease time study . Unstable angina history myocardial infarction congestive heart failure within 6 month prior enrollment study Renal insufficiency chronic kidney disease stage 4 5 ( GFR &lt; 30 mL/min/1.73m2 ) Crohn 's disease active intestinal inflammatory condition Having ileal resection Diabetic Gastroparesis Pregnancy intent become pregnant . Urine pregnancy test perform prior HQ SHUNT test . Inability consent one 's self</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hepatic Venous Pressure Gradient ( HVPG ) test</keyword>
	<keyword>HepQuant-SHUNT</keyword>
	<keyword>Liver Function</keyword>
</DOC>